Barbara Eichhorst, Jennifer Brown

The BeiGene Satellite Symposium at the XIIIth International Workshop of the German CLL Study Group 2022 was chaired by Prof Barbara Eichhorst and joined by Prof Jennifer Brown. They discussed the current approaches and future direction of targeted therapy with BTK inhibitors for CLL patients.

BeiGene

BeiGene wants to ensure access to medicines for all patients and puts patients first in the fight against cancer. We foster strong collaborations that extend to the furtherest reaches of the globe. Learn more about the BeiGene story.

Chat with BeiGene

Close